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Abstract 
Objective    Breast cancer is the most commonly diagnosed cancer in women across the world. 
The majority of women diagnosed with the disease undergo surgery, which is often associated 
with significant psychosocial morbidity. The aim of this meta‐analysis was to identify the efficacy 
of psychosocial interventions for women following breast cancer surgery. 
 
Method  A comprehensive literature  search was undertaken using keyword  and subject 
headings within 7 databases. Included studies employed a quantitative methodology presenting 
empirical findings focusing on interventions for female breast cancer patients following surgery. 
Results   Thirty‐two studies were included and based on conventional values of effect sizes. 
Small effects emerged for  the efficacy of  psychosocial interventions  in relation to  anxiety 
(Hedges g = 0.31), depression (0.38), quality of life (0.40), mood disturbance (0.31), distress 
(0.27), body image (0.40), self‐esteem (0.35), and sexual functioning (0.22). A moderate to large 
effect emerged for the efficacy of interventions in promoting improvements in sleep disturbance 
(0.67). Clear evidence emerged for the efficacy of cognitive behavioral therapy in promoting 
improvements in anxiety, depression, and quality of life. 
Conclusion    This is the first meta‐analysis to demonstrate the efficacy of interventions on a 
range of psychosocial outcomes following breast cancer surgery. The meta‐analysis highlighted 
that cognitive behavioral therapy was consistently the most effective psychosocial intervention 
promoting improvements in anxiety, depression, and quality of life. However, there are short- 
comings in existing studies; the length of the follow‐up period is typically short and the genera- 
lizability of findings was limited by small samples, both of which should be addressed in future 
studies. 
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1   |    INTR ODUC TION  
 
 
Breast cancer is the  most commonly diagnosed cancer in women 
across the world.1  It is estimated that 1 out of every 8 women will 
develop breast cancer at some point in their lives.2  Mortality  rates 
have fallen over recent decades partly because of advances in early 
detection and treatment,3  resulting in a growing cohort of breast 
cancer survivors.4  Improved survival rates have placed increased 
importance on promoting and supporting a high quality of life and 
optimal psychosocial adjustment among breast cancer patients. The 
primary treatment for breast cancer is surgical, consisting of either a 
mastectomy or breast conservation surgery.1 Following mastectomy, 
approximately one‐third of  women choose to  undergo immediate 
breast reconstruction5  in order to reconstruct or reshape the breast 
mound. 
Breast cancer diagnosis and treatment is associated with increased 
rates of anxiety, depression, distress, and reduced quality of life.6  The 
period following breast cancer surgery is also associated with conside- 
rable  psychosocial morbidity7    with  as many  as 30%  of  women 
experiencing anxiety and depression.6 Body image issues and sexual 
 
difficulties are also significantly higher following surgical treatment for 
breast cancer.8 However, it is often assumed that the distress expe- 
rienced by women with breast cancer abates after the initial treatment, 
yet stress‐related symptoms may actually increase after surgery and 
treatment completion, as patients leave the “safety net” provided by 
contact with  the oncology team.7  A recent meta‐analysis suggested 
anxiety after a diagnosis of cancer may persists for up to 10 years or 
more.9  Collectively, these findings underscore the need to  address 
the psychosocial well‐being of breast cancer patients following surgical 
treatment and reconstruction. 
The past decade has seen an increase in the development of inter- 
ventions to reduce psychosocial morbidity and improve coping and 
adjustment following breast cancer treatment. Psychosocial interven- 
tions are broadly defined as any supportive interaction involving 2 or 
more individuals whose purpose is to  promote  awareness and 
education, provide emotional support and encouragement, and assist 
with  problem solving.10   Psychosocial interventions  that  have been 
utilized with  breast cancer patients following surgery include group 
therapy, individual counseling, psychotherapy, and psychoeducational 
interventions.11,12   Generally, such interventions  have only focused 
on a limited number of patient outcomes, including anxiety, depres- 
sion, and quality of life. Nevertheless, accumulating evidence indicates 
psychosocial interventions provide a consistent  beneficial effect for 
cancer patients13  and specifically breast cancer patients.11  However, 
little  is known about which intervention is most effective following 
breast cancer surgery. The aim of this systematic review and meta‐ 
analysis was to evaluate the efficacy of interventions on a range of 
psychosocial outcomes following surgical treatment for breast cancer, 
both mastectomy and breast conservation surgery. 
 
 
 
2   |    METHODS  
 
 
2.1  |   Search, selection, and review strategies 
 
Two chartered health psychologists, a medical librarian, and a consul- 
tant plastic surgeon formed part of the panel to develop an appropriate 
search strategy. Four methods were used to identify relevant studies: a 
keyword search, a subject search, a backward search, and a forward 
search. Literature  searches were  performed  using  7  electronic 
databases: PsycINFO (1976‐2015), CINAHL (1998‐2015), MEDLINE 
(1975‐2015), Academic Search Complete (1980‐2015), AMED (1996‐ 
2014), Cochrane Library (1975‐2015), and EMBASE (1974‐2015). 
The  search terms  were  grouped  into  3  blocks: block  1—breast 
neoplasms,  breast oncol*, breast cancer, breast tumor, and breast 
tumour; block 2—mastectom*, lumpectom*, and prophylactic; and 
block 3—family therap*, group therap*, psychosocial rehabilitation, 
anxiety management, relaxation therap*, cognitive therap*, cognitive 
behaviour*, therap*, social support, support groups, counsel*, counsel- 
ling, counselling, group counsel, group counselling, and group counsel- 
ling. The terms relating to the types of surgical procedures (block 2) 
were combined with OR and NOT prophylactic, referring to prophylac- 
tic mastectomy. Terms within  each block were combined using OR, 
and then the results of each block were combined using the AND 
function. Duplicates were excluded. This study was approved by a 
university ethics committee, and a review protocol  was developed 
and followed but is not available to access. 
Inclusion criteria were as follows: (i) female adult breast cancer 
survivors; (ii) any type  of  primary breast cancer surgery including 
mastectomy and breast conservation surgery; (iii) psychological, 
psychoeducational, and/or  psychosocial intervention;  (iv) written  in 
English; (v) quantitative  methodology; and (vi) presenting empirical 
findings. Studies were excluded if interventions focused on physical 
rehabilitation, physiological outcomes, and palliative and/or meta- 
static breast cancer and were published as a conference abstract 
or  a  case study.  A  backward (reference)  search was performed, 
which involved hand searching the reference list of articles included 
in the analysis. A forward (citation) search was also performed using 
Scopus.  Additionally, as part  of  the  systematic search procedure, 
review  articles were  also obtained and examined to  identify  any 
additional articles. 
Two blinded raters (H.M. and E.G.) independently applied a 14‐ 
item quality assessment checklist from a standardized quality assess- 
ment tool to each study.14  Discrepancies were systematically resolved 
by consensus. Each study was assessed against the 14 items using a 3‐ 
point  scale (2 fully  met, 1 partially met, and 0 did not  meet the 
criterion). A total score was calculated by summing the number of 
“yes” responses, multiplying this by 2, and adding this to the number 
of partials. If a criterion was not applicable, it was excluded from the 
score calculation. The total possible score was calculated  as 28 minus 
2 times the number of not applicable. Lastly, a summary score (total 
sum/total possible sum) was calculated, representing the methodolo- 
gical quality of each article. These scores were calculated as a linear 
score from 0 to 100 and divided into 3 categories representing low, 
moderate, or high‐quality studies. Studies with a score of 75 or more 
were considered as high quality, 50 to 74 as moderate quality, and 
49 or less as low quality. 
 
 
2.2  |   Meta‐analysis strategy 
We used Hedges g as the effect size statistic. Hedges g calculates 
the  difference between intervention  and control  group means (d) 
divided by the pooled standard deviation multiplied by a factor (J) 
that corrects the underestimation of the population standard deviation.15 
Through pooling variances,  Hedges g standardizes  outcomes across 
studies and allows for comparison among disparate outcome measures. 
Effect size calculations used a random‐effects model. This assumes that 
analyzed studies represent a random sample of effect sizes, subsequently 
facilitating the generalizability of results.16  The heterogeneity between 
studies was calculated using the heterogeneity I2 statistic. The I2 statistic 
calculates what proportion (0‐100%) of the observed variance reflects 
variance in true effect sizes, rather than sampling error. A value of 0% 
represents no observed heterogeneity, and an I2  value of 25%, 50%, or 
75% tentatively signifies low, moderate, or high heterogeneity between 
studies, respectively.17 To minimize heterogeneity, when studies reported 
outcomes at multiple time points, the furthest time point was used to 
calculate effect size. We used the conventional values of effect size18 in 
this analysis. An effect size of 0.2 demonstrated a small effect,  0.5 a 
moderate effect, and 0.8 a large effect. We used the Comprehensive 
Meta‐Analysis software for all statistical analyses.19
 
  
2.3  |   Sources of bias 
 
Mean effects for  each outcome were assessed  for  the degree of 
publication bias (the preferential publication of studies with positive 
effects). Publication bias was assessed  using two  techniques: the 
examination of the funnel plot and estimates of correction, trim and fill. 
If  the  points  on  the  funnel  plot  are evenly distributed  between 
positive and negative effects, bias is lacking within the meta‐analysis. 
If publication bias exists, a disproportionate number of studies will fall 
to the bottom right of the plot.20  The trim and fill method attempts to 
estimate the number of missing studies that may exist in the meta‐ 
analysis and correct for  funnel plot  asymmetry.20  Orwin's fail‐safe 
N was also calculated to assess the roboustness of the overall effect.21 
This will  determine the  number of  studies with  a null effect  size 
required to reduce the overall effect to non‐significant. In this meta‐ 
analysis, the number of studies is represented by k. 
 
 
 
2.4  |   Systematic review results 
 
The search strategy identified 3817 records, reduced to 1455 unique 
articles following the exclusion of duplicates and to 19 articles follo- 
wing the application of the inclusion and exclusion criteria (Figure 1). 
A backwards search identified  8 additional articles,  and a forward 
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FIGURE 1    Flow diagram depicting the systematic review process 
  
search identified 7 further  articles,  totaling 34 articles. Twenty‐one 
articles were classified as high quality, 11 as moderate quality, and 2 
as low quality (Table 1). The two low‐quality articles were removed 
from the review. In total, 32 articles were included in the review. 
Twenty‐two  studies utilized a randomized controlled trial design, 5 
pre– and post–group evaluations, 2 nonrandomized controlled studies, 
2 single cohorts pre‐evaluation and postevaluation, and 1 randomized 
and comparative study design. Follow‐up periods ranged from 1 to 
36 months with between 2 and 6 data collection points. 
Participant and design characteristics of the 32 studies included in 
this review are summarized in Table 1, and outcome and assessment 
measures are described in detail in Table S3, accessible as supporting 
information. This review comprised of 32 psychosocial interventions 
with   8  studies  utilizing  cognitive  behavioral  therapy  interven- 
tions,10,22–28    7   psychoeducational  interventions,29–35    4   support 
groups,36–39 three counseling interventions,40–42  2 mindfulness‐based 
stress reduction  interventions,43,44   2  supportive‐expressive group 
therapy interventions,45,46  1 psychosexual intervention,47  one music 
therapy and progressive muscle relaxation training,48 and 1 contempla- 
tive self‐healing intervention.49 The review also included 2 studies that 
combined psychoeducational interventions and peer and social 
support interventions50,51  and 1 intervention that combined cognitive 
behavioral therapy, social support, and psychoeducational elements.52 
Twenty‐five interventions were delivered in person, 6 interventions 
were delivered via telephone, and 1 intervention via videoconferen- 
cing. The number of intervention sessions ranged from a single session 
to 30 sessions. The studies reported sample sizes ranging from 20 to 
442, and the total number of participants across all studies included 
in this review was 4148. Twenty‐nine of 32 studies reported signifi- 
cant treatment effects in 1 or more examined outcomes. 
 
 
 
 
2.5  |   Anxiety 
 
Eight of 13 studies reported a significant reduction in anxiety following 
the intervention.23,27,39,44–48  While two studies demonstrated sig- 
nificant effects with  cognitive behavioral therapy on anxiety,23,27  2 
studies reported no significant effects with cognitive behavioral 
therapy.10,26 Counselling interventions also failed to demonstrate sig- 
nificant treatment effects on anxiety.32,40,42  Moreover, Kimman and 
colleagues32 reported no significant treatment effects of a telephone 
educational intervention on anxiety. 
 
 
 
2.6  |   Depression 
 
Thirteen  studies  reported  a  significant   reduction  in  depression 
across a range of  interventions including cognitive behavioral the- 
rapy,22,25–27    psychoeducational intervention,30    counseling,40    sup- 
portive‐expressive group therapy,45,46   videoconferencing support 
groups,36   psychosexual intervention,47   mindfulness‐based stress 
reduction,44   support groups,39   and music therapy and progressive 
muscle relaxation training.48   No significant treatment effect  was 
reported for  telephone counseling,41  psychoeducation, and peer 
modeling on depression.35 
2.7  |   Quality of life 
 
Thirteen studies reported improved quality of life across a range of 
interventions  including contemplative self‐healing intervention,49 
psychoeducational interventions,31   mindfulness‐based  stress reduc- 
tion,43  cognitive behavioral therapy,25–27,34,42 and combined interven- 
tions  utilizing  psychoeducation, cognitive  behavioral therapy, and 
social support3  and a psychoeducational and peer support interven- 
tion.50   Support groups37  and 2 psychoeducational interventions32,33 
reported no significant treatment effects on quality of life. 
 
 
2.8  |   Mood disturbance 
 
Five studies reported a significant improvement in mood with suppor- 
tive‐expressive group therapy,45,46  mindfulness‐based stress reduc- 
tion,43  telephone cognitive behavioral therapy,10  and counseling.42 In 
contrast, 2 psychoeducational interventions reported no significant 
treatment effect on mood disturbance.29,51 
 
 
2.9  |   Distress 
 
In 2 psychoeducational interventions29,35  and a telephone counseling 
intervention,41  no significant  treatment effect was demonstrated in 
lowering distress. In contrast, there were modest improvements in 
distress after cognitive behavioral therapy,22 a support group interven- 
tion,38  and a relaxation intervention,24 which all reported a significant 
reduction  in  distress. However,  1  psychoeducational intervention 
reported an increase in distress post intervention.29 
 
 
2.10  |   Body image 
 
Two studies reported significant treatment effects with cognitive 
behavioral therapy24  and support groups.37 In contrast, no significant 
treatment effect on body image was observed for supportive‐expres- 
sive group therapy.46 
 
 
2.11  |   Sleep disturbance 
 
Two  studies  utilizing  supportive‐expressive group  therapy46    and 
cognitive behavioral therapy27   reported improved sleep. One study 
reported that a reduction in sleep disturbance was associated with 
decreased anxiety and depression and improved global quality of life.31 
 
 
2.12  |   Self‐esteem 
Group cognitive behavioral therapy reported a significant  improve- 
ment in self‐esteem.26,28 In contrast, studies utilizing support groups38 
and couple counseling40 reported no significant treatment effects for 
self‐esteem. 
 
 
2.13  |   Sexual functioning 
 
Two studies reported significant improvements in sexual dysfunction 
through counseling.40,41 The control group showed virtually no change 
from baseline, suggesting that this source of psychosocial morbidity 
may  be  especially resistant  to  improvement  in  the  absence of 
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TABLE 1    Systematic review of psychosocial interventions for women after breast cancer surgery (k = 32) 
 
 
Authors Study design 
 
Sample 
size Intervention  Measures Outcomes 
 
Quality 
rating 
Antoni et al, 2001, USA RCT Int: 46 Cognitive behavioral 
therapy 
The Profile of Mood 
States 
Distress: 1.77, 
F = 2.33 
High 
Comp: 53 Center for 
Epidemiologic 
Studies Depression 
Scale 
Life Orientation Test— 
Revised 
Depression: Int, 
Q = 13.60**; 
Comp, 
Q = 2.67 
Optimism: Int 
2.81; Comp 
20.15, 
F = 6.96*** 
Antoni et al, 2009, USA RCT Int: 63 Cognitive behavioral 
therapy 
Impact of Event Scale Anxiety: 
F = 3.86* 
High 
Comp: 65 Hamilton Rating Scale 
for Anxiety 
 
Affects Balance Scale 
Intrusive 
thoughts: 
F = 3.24* 
Ashing and Rosales, USA RCT Int: 100 Psychoeducational 
intervention 
 
 
 
 
Comp: 99 
20‐item Center for 
Epidemiologic 
Studies Depression 
Scale 
Depression: Int 
25.4 ± 17.2***; 
Comp 
14.8 ± 14.1* 
(CI, −5.75 to 
−0.282)* 
High 
Charlson et al, USA Pre– and post– 
group evaluation 
Int: 46 Contemplative self‐ 
healing intervention 
The Impact of Events 
Scale 
General Functional 
Assessment of 
Cancer Therapy 
Scale + Breast 
Cancer Subscale 
Functional Assessment 
of Chronic Illness 
Therapy Spirituality 
Scale 
QoL: 4.6 ± 10.9* High 
 
Spirituality: 
+1.4 ± 1.0 
 
 
 
Breast cancer– 
specific QoL: 
+4.8 ± 12.8 
Cho et al, Asia  Nonrandomized 
and comparative 
Int: 28        Psychoeducational 
intervention and 
peer support 
18‐item Psychosocial 
Adjustment Scale 
Psychosocial 
adjustment: Int 
49.1 ± 52.1***; 
Comp 
50.3 ± 4.73 
Moderate 
Comp: 27 27‐item Quality of 
Life Scale 
 
Christensen, USA RCT Int: 10 Couples counseling Locke‐Wallace Martial 
Adjustment Test 
 
Comp: 10 Sexual Satisfaction 
Scale 
 
 
 
Beck Depression 
Inventory 
 
 
Rosenberg Self‐esteem 
Scale 
 
Spielberger State‐Trait 
Anxiety Inventory 
QoL: Int 
6.2 ± 7.0**; 
Comp 6.4 ± 6.3 
Martial happiness: 
Int 106.15; 
Comp 99.6 
Sexual 
functioning: Int 
80.41; Comp 
69.04, 
F = 33.92* 
Depression: Int 
98.18; Comp 
12.02, 
F = 7.53* 
Self‐esteem: Int 
17.5; Comp 
17.8 
Anxiety: Int 39.9; 
Comp 40.5 
 
 
 
 
Moderate 
 
Classen et al, USA RCT Int: 178 Supportive‐expressive 
group therapy 
The Profile of Mood 
States 
Questionnaire 
Mood: Int 13.69, 
F = 4.7*; Comp 
9.05, F = 6.5*** 
High 
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TABLE 1    (Continued) 
 
 
Authors Study design 
Sample 
size Intervention  Measures Outcomes 
Quality 
rating 
Comp: 
179 
The Hospital Anxiety 
and Depression 
Scale 
Anxiety: Int, 
F = 5.4*; Comp, 
F = 6.3** 
 
Yale Social Support 
Index 
 
Depression: Int, 
F = 5.2*; Comp, 
F = 5.3* 
Social support: Int, 
F = 6.0*; Comp 
5.4* 
Coleman et al., USA                               RCT                 Int: 54        Psychoeducational 
intervention and 
social support 
Profile of Mood States Mood: NS High 
 
 
 
 
 
 
 
 
 
Collie et al, USA Pre– and post– 
group evaluation 
The Visual Analogue 
Scale—Worry 
Comp: 52 The Relationship 
Change Scale 
 
The 20‐item University 
of California, Los 
Angeles, Loneliness 
Scale—Version 3 
Int: 27 Support groups Center for 
Epidemiologic 
Studies Depression 
Scale 
The Cancer Behavior 
Inventory 
 
Courtauld Emotional 
Control Scale 
 
Cancer‐related 
worry: NS 
Relationships: NS 
Loneliness: NS 
 
 
Depression: 
t = 2.44*; 
d = 0.51 
 
Emotional 
expression: 
t = 0.44 
Self‐efficacy: 
t = 0.71 
 
 
 
 
 
 
 
 
 
Moderate 
Dow Meneses et al, USA RCT Int: 125 Psychoeducational 
intervention 
 
Comp: 
131 
QoL—Breast Cancer 
Survivors 
QoL: Int −1.687; 
Comp 
−2.909*** 
High 
Esplen et al, USA RCT Int: 128 Support groups Body Image Scale Body image: Int 
18.3 ± 15.3; 
Comp 
18.5 ± 17.3* 
High 
Objectified Body 
Consciousness 
Scale 
 
Comp: 65 Mental Adjustment to 
Cancer Scale 
 
 
 
Female Sexual 
Function Index 
Social Support 
Survey 
 
Functional Assessment 
of Cancer Therapy— 
Breast 
Body stigma: Int 
37.5 ± 34.3; 
Comp 
37.5 ± 37.4*** 
Sexual 
functioning: Int 
13.5 ± 15.2; 
Comp 
12.1 ± 12.7 
QoL: Int 
91.2 ± 94.8; 
Comp 
89.8 ± 92.4 
Fadaei et al, Iran RCT Int: 32 Cognitive behavioral 
therapy 
 
 
 
Comp: 40 
Body Image Scale Body image: Int 
16.97 ± 9.03, 
t = −6.07***; 
Comp 
15.95 ± 17.18 
Moderate 
 
Fobair et al, USA  Single cohort 
pre‐evaluation 
and 
postevaluation 
Int: 20 Supportive‐ 
expressive group 
therapy 
The Impact of Event 
Scale 
Mood: t = −2.43* High 
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Authors Study design 
Sample 
size Intervention  Measures Outcomes 
Quality 
rating 
The Profile of Mood 
States 
The Hospital Anxiety 
and Depression 
Scale 
The Mini‐Mental 
Adjustment to 
Cancer 
The Body Image and 
Sexuality Scale for 
Women With Breast 
Cancer 
The Family Relations 
Index 
The Social Network 
and Support 
Assessment 
The Medical 
Interaction Scale of 
the Cancer 
Rehabilitation 
Evaluation System 
The Impact of Illness 
on Your Life 
Questionnaire 
Structured Insomnia 
Interview 
Anxiety: 
t = −2.52* 
Depression: 
t = −3.11** 
 
Coping: 
t = −3.57** 
 
Body image: 
t = 0.71 
 
 
Relationships: 
t = −2.78** 
Social support: 
t = −2.42* 
 
Impact of illness 
on life: 
t = −1.62 
 
 
Sleep: t = 2.27* 
 
Gunn et al, Australia Pre– and post– Int: 44 Support groups Profile of Mood States Distress: Moderate 
 group evaluation    t = 3.44***  
The Coopersmith Self‐ 
Esteem Inventory 
 
The Duke‐UNC 
Functional Social 
Support 
Questionnaire 
Self‐esteem: 
t = −0.55 
Social support: 
t = 0.77 
 
Hoffman et al, UK RCT Int: 103 Mindfulness‐based 
stress reduction 
Profile of Mood States Mood: CI, −21.02 
to −4.81)*** 
High 
Comp: 
111 
 
 
 
 
Jones et al, Canada RCT Int: 216 Psychoeducational 
intervention 
 
Comp: 
226 
Functional Assessment 
of Cancer Therapy— 
Breast 
WHO five‐item Well‐ 
being Questionnaire 
Knowledge 
Questionnaire 
 
Perceived 
preparedness for 
reentry scale 
 
Self‐Efficacy for 
Managing Chronic 
Disease 
QoL: CI, 4.16 to 
10.68*** 
 
Well‐being: CI, 
1.16 to 3.15*** 
Knowledge: 0.718 
(CI, 0.418 to 
1.017)*** 
Perceived 
preparedness: 
0.409 (CI, 0.273 
to 0.545)*** 
Self‐efficacy: 
−0.221 (CI, 
−0.510 to 
0.068) 
 
 
 
 
 
 
High 
Profile of Mood States Mood: 0.859 (CI, 
−2.398 to 
4.116) 
Health Distress Scale Distress: 0.114 
(CI, −0.035 to 
0.262) 
Kalaitzi et al, Greece RCT Int: 20 Psychosexual 
intervention 
Spielberger's State‐ 
Trait Anxiety 
Inventory 
Depression: Int 
<0.001***; 
Comp: P < .236 
Moderate 
 
(Continues) 
  
(Continues) 
 Sample    Quality 
Authors Study design size Intervention Measures Outcomes rating 
Comp: 20 Center for 
Epidemiologic 
Studies Depression 
Scale 
Questionnaire 
assessing sexuality 
and body image 
Anxiety: Int, 
P < .006**; 
Comp, P < .645 
 
Kimman et al, the Netherlands RCT Int: 149 Psychoeducational 
intervention 
EORTC QoL 
Questionnaire 
QoL: NS High 
  Comp:  State‐Trait Anxiety Anxiety: NS  
  150  Inventory   
Kionberg et al, Sweden Nonrandomized Int: 50 Psychoeducational The Functional Well‐being: NS High 
 controlled study  intervention Assessment of   
    Cancer Therapy   
    General Scale   
  Comp: 46  Sense of Coherence Sense of  
    Scale coherence: NS  
Lengacher et al, USA RCT Int: 41 Mindfulness‐based 30‐item Concerns Fear of High 
   stress reduction about Recurrence recurrence: Int  
    Scale 9.3; Comp  
     11.6**  
  Comp: 43  The State‐Trait State anxiety: Int  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manos et al, Spain Nonrandomized 
controlled study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Int: 94 Psychoeducational 
intervention and 
cognitive behavioral 
therapy and social 
support 
Anxiety Inventory 
 
Epidemiological 
Studies Depression 
Scale 
6‐item Life 
Orientation Test 
 
10‐item Perceived 
Stress Scale 
 
19‐item Medical 
Outcomes Social 
Support Survey 
EORTC QoL 
Questionnaire 
28.3; Comp 
33.0* 
Depression: Int 
6.3; Comp 9.6* 
 
Optimism: Int 
46.7; Comp 
44.9 
Perceived stress: 
Int 12.6; Comp 
14.4 
Social support: 
Int 12.4; Comp 
12.8 
QoL: 
F = 25.173** 
 
 
 
Anxious 
preoccupation: 
F = 16.036** 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moderate 
Comp: 94 Mental Adjustment to 
Cancer Scale 
Fighting spirit: 
F = 55.345** 
Optimism: 
F = 18.413** 
Marchioro et al, Italy RCT Int: 18 Cognitive behavioral 
therapy 
Functional Living 
Index Cancer 
QoL: Int 41.17; 
Comp 60.28*** 
Moderate 
Comp: 18 The Beck Depression 
Inventory 
Depression: Int 
4.83; Comp 
8.17*** 
Marcus et al, USA RCT Int: 152 Counseling Impact of Event Scale Distress:  P = .29; 
r = 0.24 
High 
Comp: 
152 
Center for 
Epidemiologic 
Studies Depression 
Scale 
The Sexual 
Dysfunction Scale 
Depression: 
P = .48; r = 0.23 
 
 
Sexual 
functioning: 
P = .04; 
r = 0.23* 
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Authors 
 
Study design 
Sample 
size 
 
Intervention 
 
Measures 
 
Outcomes 
Quality 
rating 
Montazeri et al, Iran Single cohort 
pre‐evaluation 
Int: 56 Support groups The Hospital Anxiety 
and Depression 
Anxiety: t = 2.21* Moderate 
and 
postevaluation 
 
 
 
Qui et al, China RCT Int: 31 Cognitive behavioral 
therapy 
Scale 
 
 
 
17‐item Hamilton 
Depression Rating 
Scale 
 
Self‐rating Anxiety 
Scale 
 
 
Depression: 
t = 2.75** 
Depression: Int 
7.51; Comp 
14.35 
(ES = 1.51)*** 
Anxiety: Int 
37.74; Comp 
43.10 (ES = 
0.66) 
 
 
 
 
High 
Comp: 31 Functional Assessment 
of Cancer Therapy— 
Breast 
Self‐esteem: Int 
28.42; Comp 
27.00 
  (ES = 0.63)*  
Self‐esteem Scale QoL: Int 97.17; 
 Comp 89.85 
 (ES = 0.53)** 
Sandgren et al, USA RCT Int: 24 Cognitive behavioral Coping Response Distress: Int 8.2; High 
therapy Indices—Revised Comp 7.4, 
    F = 4.48*  
 Comp: 29  Profile of Mood States Coping cognitive:  
    Int 28.9; Comp  
    26.7  
    Coping  
    behavioral: Int  
    31.5; Comp  
    20.8  
    Coping avoidant:  
    Int 11.2; Comp  
    12.0  
    Anxiety: Int 2.9;  
    Comp 3.6,  
    F = 6.29*  
    Mood: Int 2.0;  
    Comp 3.0,  
    F = 3.15*  
Savard et al, Canada RCT Int: 27 Cognitive behavioral Insomnia Severity Sleep: High 
  therapy Index F = 11.70***  
   Hospital Anxiety and Anxiety:  
   Depression Scale F = 5.19*  
 Comp: 30  EORTC QoL Depression:  
Questionnaire F = 4.14* 
 
Sharif et al, Iran RCT Int: 49 Psychoeducational 
intervention 
 
EORTC QoL 
Questionnaire 
QoL: F = 5.69* 
QoL: Int 80.0; 
Comp 61.66*** 
 
High 
Comp: 50 
Stanton et al, USA RCT Int: 143 Psychoeducational 
intervention 
 
Comp: 
136 
 
 
4‐item Short‐Form 
Vitality Subscale 
 
Revised Impact of 
Events Scale 
 
Center for 
Epidemiologic 
Studies Depression 
Scale 
 
 
Vitality: Educ 
7.36; Comp 
6.60 
Distress: Educ 
−0.07; Comp 
−0.08 
Depression: Educ 
−0.68; Comp 
−1.79 
 
 
High 
 
 
 
 
 
 
 
 
 
(Continues) 
  0.95 to 6.52); 
t = 2.64** 
 
Watson et al, UK Pre– and post– 
group evaluation 
Int: NR Counseling Profile of Mood States Mood: Int, 
t = 2.98*; 
Comp, t = 2.3* 
Moderate 
  Comp: 
NR 
 Spielberger State‐Trait 
Anxiety Inventory 
Anxiety: Int 0.5; 
Comp 4.5 
 
Wojtyna et al, Poland Pre– and post– 
group evaluation 
Int: 35 Cognitive behavioral 
therapy 
EORTC QoL 
Questionnaire 
QoL: Int 64.76; 
Comp 54.86, 
F = 6.33* 
Moderate 
 
Depression 12 0.38 0.24–0.52 0.001 Q = 21.52, p = 0.04, I
2 = 44.23 198 
Anxiety 10 0.31 0.19–0.43 0.001 Q = 12.71 p = 0.24, I
2 = 21.33 81 
Quality of Life 10 0.40 0.27–0.54 0.001 Q = 20.48 p = 0.04, I
2 = 46.29 189 
Body Image 3 0.40 0.16–0.63 0.001 Q = 21.68 p = 0.33, I
2 = 7.74 7 
Sexual functioning 3 0.22 0.07–0.50 0.14 Q = 3.63, p = 0.16, I
2 = 44.89 2 
Sleep disturbance 2 0.67 0.29–1.05 0.001 Q = 1.19 p = 0.27, I
2 = 16.52 N/A 
Self‐esteem 3 0.35 0.00–0.69 0.05 Q = 4.14 p = 0.12, I
2 = 51.71 4 
Mood disturbance 4 0.31 0.12–0.51 0.001 Q = 8.95 p = 0.06, I
2 = 55.33 35 
Distress 5 0.27 0.05–0.49 0.02 Q = 11.41 p = 0.01, I
2 = 73.72 9 
 
 
Authors Study design 
Sample 
size Intervention  Measures Outcomes 
Quality 
rating 
Posttraumatic Growth 
Inventory 
 
 
Perceived 
preparedness for 
reentry 
Posttraumatic 
growth: Educ 
5.44; Comp 
2.43 
Perceived 
preparedness: 
B = 3.73 (CI, 
 
 
 
 
 
 
 
 
 
 
Comp: 32 R. Cibor's Self‐esteem 
Scale 
Self‐esteem: Int 
27.06; Comp 
32.91, F = 4.46* 
Zhou et al, China RCT Int: 85 Music therapy and 
progressive muscle 
relaxation training 
Zung Self‐rating 
Depression Scale 
Depression: 
38.29 ± 32.65, 
F = 6.91** 
High 
Comp: 85 
 
 
State Anxiety 
Inventory 
 
 
Anxiety: 
53.98 ± 41.06, 
F = 5.46* 
Abbreviations: EORTC, European Organisation for Research and Treatment of Cancer; NS, not significant; QoL, quality of life; RCT, randomized controlled trial. 
Bold emphases indicate primary study outcomes. *P < .05. **P < .01. ***P < .001. 
 
 
 
intervention.41  However, Esplen and colleagues37 reported no signifi- 
cant treatment effects with support groups and sexual functioning. 
 
 
2.14  |   Meta‐analysis results 
Weighted  average effect  sizes for  each outcome are displayed in 
Table 2, and forest  plots  are displayed in  Figure 2. Additionally, 
Table 2  details results of  analyses to  detect  publication bias and 
heterogeneity  statistics  for  each  of  the  psychosocial outcomes. 
Meta‐regression indicated that the number of sessions within an inter- 
vention  was not  a significant  moderator  of  depression (k  =  10; 
B = 0.006; P  = .49), nor was quality of  life (k  = 11; B = −0.016; 
P = .08). However, the number of sessions was a significant moderator 
for anxiety (k = 9; B = 0.015; P = .04). In regard to publication bias, all 
funnel plots displayed a greater number of studies to the right of the 
mean. However, as a disproportionate number of studies did not fall 
to the bottom  right of the plot, this suggests systematic bias does 
not significantly contribute to our estimate of the efficacy of interven- 
tions in relation to psychosocial outcomes. Funnel plots are displayed 
in Figure S3, accessible online via supporting information. Trim and fill 
procedures inputted 5 studies for depression, 1 study for anxiety, 4 
studies for quality of life, 1 study for sexual functioning, and 2 studies 
for mood disturbance and distress, and no studies were inputted for 
self‐esteem and body image. Orwin's fail‐safe N was calculated to 
assess the robustness of the overall effect for each outcome. Orwin's 
fail‐safe N indicated 198 nonsignificant studies for depression, 81 for 
 
 
TABLE 2    Mean effect sizes for psychosocial outcomes for studies with sufficientdata for the meta‐analysis 
Psychosocial outcome k Effect size (g) 95% CI p‐value Heterogeneity  Fail‐safe N 
  
 
Meta-Analysis: Depression 
 
Study name  Statistics for each study  Hedges's g and 95% CI 
Hedges's  Standard Lower   Upper 
g error     Variance    limit       limit     Z-Value  p-Value 
Ashing 2014  0.40  0.14  0.02  0.12       0.68 2.82  0.00 
Christensen  1983  0.90  0.45  0.20  0.02       1.78 1.99  0.05 
Classen 2008  0.21  0.11  0.01  0.00       0.42 1.98  0.05 
Collie 2007  0.53  0.20  0.04  0.14       0.93 2.66  0.01 
Lengacher 2009  0.48  0.22  0.05  0.05       0.91 2.18  0.03 
Marchioro 1996  1.17  0.35  0.13  0.48       1.87 3.31  0.00 
Marcus 2009  0.22  0.11  0.01      -0.01       0.44  1.88  0.06 
Montazeri 2001  0.36  0.14  0.02  0.10       0.63 2.66  0.01 
Qui 2013  0.63  0.27  0.07  0.10       1.16 2.34  0.02 
Savard 2005  0.53  0.27  0.07  0.01       1.05 2.00  0.05 
Stanton 2005  0.01  0.12  0.01      -0.22       0.25  0.12  0.91 
Zhou 2015  0.51  0.16  0.02  0.21       0.82 3.30  0.00 
0.38  0.07  0.00  0.24       0.52 5.41  0.00 
-1.00 -0.50 0.00 0.50 1.00 
Decline  of outcome        Improvement of outcome 
 
 
Meta-Analysis: Anxiety 
 
Study name  Statistics for each study  Hedges's g and 95% CI 
Hedges's  Standard Lower   Upper 
g error     Variance    limit       limit     Z-Value  p-Value 
Antoni 2009  0.35  0.18  0.03      -0.00       0.69 1.95  0.05 
Classen 2008  0.26  0.11  0.01  0.06       0.47 2.49  0.01 
Fobair 2002  0.55  0.23  0.05  0.09       1.00 2.36  0.02 
Kimman 2011  0.01  0.12  0.01      -0.21       0.24 0.10  0.92 
Lengacher 2009  0.48  0.22  0.05  0.05       0.92 2.18  0.03 
Montazeri 2001  0.29  0.13  0.02  0.03       0.56 2.16  0.03 
Qui 2013  0.13  0.26  0.07      -0.37       0.63 0.52  0.60 
Sandgren 2000  0.41  0.27  0.08      -0.13       0.95 1.48  0.14 
Savard 2005  0.60  0.27  0.07  0.07       1.12 2.23  0.03 
Zhou 2014  0.51  0.16  0.02  0.21       0.82 3.30  0.00 
0.31  0.06  0.00  0.19       0.43 4.95  0.00 
-1.00 -0.50 0.00 0.50 1.00 
 
Decline  of outcome        Improvement of outcome 
 
 
FIGURE 2    Forest plots of effect sizes for studies assessing psychosocial outcomes 
 
 
anxiety, and 189 for quality of life would be required to render the 
efficacy of the interventions trivial. The Orwin fail‐safe N analysis for 
all outcomes is displayed in Table 2. 
 
 
 
3   |    DISCUSSION  
 
To our  knowledge, this  is the  first  meta‐analysis to  evaluate the 
efficacy of  interventions  on a range of  psychosocial outcomes in 
breast cancer patients. The meta‐analysis demonstrated small effect 
sizes on 8 psychosocial outcomes: anxiety, depression, quality of life, 
mood  disturbance, distress, body  image, self‐esteem, and  sexual 
functioning. A moderate to large effect size was detected on sleep 
disturbance. Within  this meta‐analysis, anxiety (k = 14), depression 
(k = 14), and quality of life (k = 13) were the most commonly reported 
outcomes. This is not surprising given the high incidence of anxiety 
and depression after surgical treatment  for  breast cancer, with  as 
many as 30% of women reporting experiencing anxiety and depres- 
sion,6  and the widely recognized impact of anxiety and depression 
on quality of life.7   Moreover, cognitive behavioral therapy was the 
most common intervention  for  both anxiety and depression, often 
reporting significant treatment  effects.22,23,25–27  This meta‐analysis 
provides  clear  evidence for  the  efficacy  of  cognitive  behavioral 
therapy in improving outcomes in relation to anxiety,10,23,37,39 
depression,22,25,26,37   and quality  of  life.25–28  Meta‐regression indi- 
cated the number of  sessions was not  a significant  moderator of 
depression or quality of life, although we can conclude the number 
of sessions is related to effect size for the outcome anxiety. How- 
ever, we cannot conclude if  the length of the sessions moderated 
the effect  size or the timing of the intervention  or who delivered 
the  intervention,  as a large portion  of  the  studies did not  report 
significant  details of the interventions. This should be addressed in 
future  research to  develop effective  evidence‐based  interventions 
to enhance breast cancer care. 
A previous meta‐analysis demonstrated the efficacy of cognitive 
behavioral therapy following treatment for adult cancer survivors on 
anxiety,  depression, and  quality  of  life  with  a  large effect  size 
(g = 1.99), based on 4 studies.52  The findings of this meta‐analysis 
are conservative yet consistent with previous literature. Moreover, a 
meta‐analysis assessing  the  efficacy of  psychological interventions 
for breast cancer patients reported strong treatment effects for the 
efficacy of cognitive behavioral therapy in improving anxiety, depres- 
sion, and quality of life.53  This meta‐analysis is the first to demonstrate 
the  efficacy of  psychosocial interventions  to  improve a range of 
psychosocial outcomes  following  breast  cancer surgery. Previous 
literature52    has predominately focused on anxiety, depression, and 
quality of life. While these are undoubtedly important outcomes, our 
meta‐analysis goes beyond this and considers less explored yet emer- 
ging research outcomes. However, this meta‐analysis cannot conclude 
if the period following  breast cancer surgery is optimal to provide 
support for breast cancer patients; this warrants further investigation. 
Moreover, it is not clear for the other psychosocial outcomes which 
  
 
 
 
Study name 
Meta-Analysis: Quality of Life 
Statistics for each study 
 
Hedges's  Standard Lower    Upper 
g error     Variance    limit limit     Z-Value   p-Value 
 
 
 Hedges's g and 95% CI 
Charlson 2014  0.39 0.15 0.02 0.09      0.69 2.59 0.01 
Cho 2006 0.89 0.28 0.08 0.34      1.44 3.19 0.00 
Dow Meneses 2007 0.29 0.13 0.02 0.05      0.54 2.32 0.02 
Esplen 2012  0.08 0.15 0.02 -0.22      0.37 0.50 0.62 
Hoffman 2012 0.45 0.14 0.02 0.18      0.73 3.29 0.00 
Kimman 2011 0.09 0.12 0.01 -0.13      0.32 0.81 0.42 
Manos 2008 0.38 0.15 0.02 0.09      0.67 2.58 0.01 
Marchioro 1996 0.97 0.35 0.12 0.29      1.65 2.81 0.00 
Qui 2013 0.50 0.25 0.06 -0.00      1.00 1.95 0.05 
Savard 2005 0.52 0.27 0.07 0.00      1.05 1.97 0.05 
Sharif 2006 0.68 0.21 0.04 0.27      1.08 3.30 0.00 
Wojtyna 2007 0.61 0.25 0.06 0.12      1.09 2.46 0.01 
0.36 0.05 0.00 0.26      0.45 7.26 0.00 
 
 
 
 
 
 
 
 
 
 
-1.00 -0.50 0.00 0.50 1.00 
 
Decline of outcome Increase of Outcome 
 
 
Meta-Analysis: Body Image 
 
Study name Statistics for each study Hedges's g and 95% CI 
Hedges's Standard Lower  Upper 
g error    Variance  limit      limit   Z-Value  p-Value 
Esplen 2012 0.43 0.17 0.03 0.10      0.76 2.58 0.01 
Fadaei 2010 0.62 0.24 0.06 0.15      1.09 2.59 0.01 
Fobair 2002 0.15 0.22 0.05     -0.27      0.58 0.72 0.47 
0.40 0.12 0.01 0.16      0.63 3.26 0.00 
 
-1.00 -0.50 0.00 0.50 1.00 
 
Decline of outcome       Improvement of outcome 
 
 
Meta-Analysis: Sleep distrubance 
 
Study name Statistics for each study Hedges's g and 95% CI 
Hedges's  Standard Lower  Upper 
g error      Variance   limit      limit    Z-Value p-Value 
Fobair 2002 0.50 0.23 0.05 0.05      0.95 2.20 0.03 
Savard 2005 0.89 0.27 0.08 0.36      1.43 3.26 0.00 
0.67 0.19 0.04 0.29      1.05 3.46 0.00 
 
-1.00 -0.50 0.00 0.50 1.00 
 
Decline of outcome        Improvement of outcome 
 
 
Meta-Analysis: Self-esteem 
 
Study name 
Statistics for each study 
Hedges's g and 95% CI 
Hedges's Standard Lower   Upper 
g error   Variance  limit      limit   Z-Value  p-Value 
Gunn 2005 0.09 0.15 0.02     -0.20     0.38 0.58 0.56 
Qiu 2013 0.60 0.26 0.07      0.10     1.10 2.34 0.02 
Wojtyna 2007 0.51 0.25 0.06      0.03     0.99 2.08 0.04 
0.35 0.18 0.03      0.00     0.69 1.97 0.05 
 
-1.00 -0.50 0.00 0.50 1.00 
 
Improvement of outcome       Decline of outcome 
 
 
FIGURE 2    (Continued) 
 
 
intervention  would be most effective; this should be addressed in 
future  studies. Consequently, robust conclusions cannot be drawn 
surrounding which intervention would be most effective for specific 
psychosocial outcomes,  with  the exception of  cognitive behavioral 
therapy improving outcomes in relation to anxiety, depression, and 
quality of life. 
The quality of both the systematic review and meta‐analysis is 
dependent on the quality of studies analyzed. One review suggests 
the more rigorous the review, the less likely it is to conclude there 
is evidence that  psychosocial interventions in oncology are 
effective.54   Consequently, the design of the studies included must 
be considered. While the majority of studies utilized a randomized 
controlled trial study design, a number of studies employed a pretest 
and posttest design. Therefore, in the studies that employed a pre- 
test and posttest design, the findings may be attributed to changes 
that   occurred  independently  to   the   intervention;   for   example, 
  
 
Meta-Analysis: Mood distrubance 
 
Study name Statistics for each study Hedges's g and 95% CI 
Hedges's  Standard Lower  Upper 
g error    Variance    limit     limit  Z-Value  p-Value 
Classen 2008 0.35 0.11 0.01 0.14     0.56     3.29 0.00 
Fobair 2002 0.50 0.23 0.05 0.05     0.95     2.20 0.03 
Hoffman 2012 0.45 0.14 0.02 0.18     0.73     3.29 0.00 
Jones 2011 0.11 0.08 0.01 -0.04     0.26     1.41 0.16 
0.31 0.10 0.01 0.12     0.51     3.15 0.00 
-1.00 -0.50 0.00 0.50 1.00 
 
Decline of outcome      Improvement of outcome 
 
 
Meta-Analysis: Distress 
 
Study name Statistics for each study Hedges's g and 95% CI 
Hedges's   Standard Lower  Upper 
g error    Variance     limit     limit  Z-Value  p-Value 
Antoni 2001 0.31 0.20 0.04 -0.09     0.70     1.52 0.13 
Gunn 2005 0.52 0.16 0.03 0.21     0.83     3.31 0.00 
Jones 2013 0.02 0.05 0.00 -0.09     0.12     0.33 0.74 
Marcus 2010 0.21 0.11 0.01 -0.02     0.43     1.81 0.07 
Sandgren 2000      0.57 0.28 0.08 0.03     1.12     2.06 0.04 
0.27 0.11 0.01 0.05     0.49     2.35 0.02 
 
-1.00 -0.50 0.00 0.50 1.00 
 
Decline of outcome      Improvement of outcome 
 
 
FIGURE 2    (Continued) 
 
 
increased support from family members may improve psychosocial 
well‐being. A number of  studies acknowledge an absence in ran- 
domization and/or  the  process of  randomization did not  result in 
equity  between groups. Therefore, further  evidence with  random- 
ized controlled trial study designs may be required to confirm signif- 
icant treatment effects are not linked to weaker study design. This 
meta‐analysis did not include unpublished studies, as we considered 
published peer‐reviewed studies would  provide the  strongest evi- 
dence regarding the  efficacy of  psychosocial interventions.  How- 
ever, we  recognize effect  sizes may be  overestimated with  the 
absence of  publication of  null findings.  This review  also reported 
both primary and secondary outcomes of studies within  the meta‐ 
analysis. Subsequently,  we acknowledge the possibility of reporting 
small effect  sizes for  secondary outcomes. Seven studies were 
excluded because the published data were not  suitable for  meta‐ 
analysis, and the  required  data could  not  be  obtained  from  the 
authors.11,23,25,37,39,44,48 
The studies included in this meta‐analysis present a number of 
limitations. The majority of the studies recruited a sample of highly 
educated, middle‐class White  women who were likely to  be moti- 
vated to participate in health research. Furthermore, 3 studies26,30,45 
utilized samples with clinically depressed and highly distressed partic- 
ipants, and another study included women experiencing chronic 
insomnia.27  Consequently, a significant improvement  is more likely, 
as participants who experience considerable psychological symptoms 
may be more likely to engage in interventions and hence benefit more 
from the intervention,  enhancing the likelihood of detecting signifi- 
cant treatment effects.55  We recommend that researchers should be 
aware of  the  sample when assessing  the  findings. Future studies 
may want  to  consider screening for  psychological symptoms and 
including only  those participants with  elevated scores. This would 
allow for resources to be targeted at those who would benefit most 
from  the  intervention  and reduce the  likelihood of  bias from  the 
ceiling/floor  effects. 
Seven studies acknowledged limited generalizability from small 
sample sizes (n < 50) and hence were underpowered to  evaluate 
changes in the multiple outcomes that were measured.25,36,38,40,46,47,49 
Notably, studies with low statistical power have a reduced chance of 
detecting a true effect.56   A number of studies also reported limited 
generalizability from single‐center trials, and the use of a single highly 
trained therapist within the interventions. Furthermore, many of the 
interventions included multiple components; subsequently, it is often 
not possible to determine which component an improvement is attrib- 
utable to. As Czaja and colleagues58 acknowledged, the decomposition 
of psychosocial interventions to identify effective components is an 
important  goal within  the field of  psycho‐oncology and should be 
addressed in future  studies. Moreover, no studies included in this 
meta‐analysis evaluated the cost‐effectiveness of interventions. How- 
ever, there is a pressing need for studies to address cost issues for 
breast cancer interventions to determine if the initial intervention cost 
becomes cost‐effective over time.56   For example, a reduction in the 
number of general practitioner visits may result in overall cost‐effec- 
tiveness of an intervention.57  We recommend future investigators to 
consider the cost‐effectiveness of interventions, particularly consider- 
ing different modes of administration (ie, in person or over the phone) 
to provide efficient and cost‐effective support. 
This is the first meta‐analysis to evaluate the efficacy of interven- 
tions to improve a range of psychosocial outcomes following breast 
cancer surgery. This meta‐analysis has demonstrated the efficacy of 
cognitive behavioral therapy in improving outcomes in relation to 
anxiety, depression, and quality of life. This meta‐analysis is of signifi- 
cant importance given the potential widespread integration of 
evidenced‐based  psychosocial interventions  in  clinical cancer care. 
Future research priorities should focus on strengthening studies both 
  
conceptually and methodologically, to meaningfully pool data to 
determine which intervention  components are required to enhance 
breast cancer survivorship. Currently, robust conclusions cannot be 
determined regarding the efficacy of different types of psychosocial 
interventions.  However,  this  meta‐analysis provides a methodical, 
novel, and secure evidence base for the efficacy of cognitive beha- 
vioral therapy on anxiety, depression, and quality of  life  following 
breast cancer surgery. 
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